Clinical Trial Update: Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women [Phase 4]

View source ↗

Summary

Phase 4 trial assessing adherence-enhancement strategies for PrEP (iTAB and drug level monitoring) in women; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Prevention

Snippet

Sponsor: University of California, Los Angeles | Conditions: HIV Prevention | Phase 4 | Status: COMPLETED | Results posted: 2020-05-27